SCHEMBL3064459

SCHEMBL3064459

C[C@H](CC#N)NC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4322486 1.00
SCHEMBL16648848 1.00
SCHEMBL25966636 0.82
SCHEMBL22735780 0.82
SCHEMBL25967168 0.80 ACACB (0.36)
SCHEMBL11642485 0.80
SCHEMBL19859594 0.78 CTSS (0.36)
SCHEMBL25967009 0.78 CYP2C9 (0.42)
SCHEMBL19859599 0.78 CTSS (0.33)
SCHEMBL23894819 0.77 CTSS (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112262129-B Triazacyclododecanesulfonamide (\"TCD\") based protein secretion inhibitors 科智生命科学公司 2024-05-14 CN disclosed
CN-112262129-A Triazacyclododecane sulfonamide (\"TCD\") based protein secretion inhibitors 科智生命科学公司 2021-01-22 CN disclosed
US-20100267728-A1 3-SUBSTITUTED-1,2,3-TRIAZIN-4-ONE'S AND 3 SUBSTITUTED 1,3-PYRIMIDINONE'S FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES CORTEX PHARMACEUTICALS, INC. (US) 2010-10-21 US disclosed
EP-1874117-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY SmithKline Beecham Corporation (US) 2008-01-09 EP disclosed
WO-2006116764-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-11-02 WO disclosed
US-5637613-A ANTITUMOR AGENT; IMMUNOSUPPRESSANTS FOURNIER INDUSTRIE ET SANTE (FR) 1997-06-10 US disclosed